/PRNewswire/ Varian, a Siemens Healthineers company, today announced that the U.S. Food and Drug Administration (FDA) granted an Investigational Device.
While recommended screenings beginning at age 45 have helped decrease colorectal cancer cases in older adults, cancer rates are continuing to increase in younger populations.
A new clinical trial studying the effectiveness of a combination of immunotherapy treatments could be more effective for patients with ovarian cancer who are resistant to traditional interventions.
Government-funded initiatives such as the Cancer Moonshot support not only the primary science that often serves as a foundation for medical advances, but also ensure that patients with rare cancers are not overlooked.
In 2018, Cincinnati Cancer Advisors founder Dr. Bill Barrett, a co-chair of Cincinnati Cancer Foundation, had a revolutionary idea focused on making Cincinnati one of the best places in the U.S. to be for those facing the adversary of cancer.